Fitness landscape of human immunodeficiency virus type 1 protease quasispecies

Journal of Virology

Volumn 81, Issue 5, 2007, Pages 2485-2496

  Fernàndez, Guerau ^a   Clotet, Bonaventura ^a   Martínez, Miguel Angel ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

ARTICLE; CASE REPORT; ENZYME ACTIVITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; UNINDEXED SEQUENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; DNA, VIRAL; GENES, VIRAL; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS); VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847210305     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01594-06     Document Type: Article

References (64)

1. Bandelt, H. J., P. Forster, and A. Rohl. 1999. Median-joining networks for inferring intraspecific phylogenies. Mol. Biol. Evol. 16:37-48.
2. Bracho, M. A., A. Moya, and E. Barrio. 1998. Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J. Gen. Virol. 79:2921-2928.
3. Briones, C., E. Domingo, and C. Molina-Paris. 2003. Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus. J. Mol. Biol. 331:213-229.
4. Brown, A. J. 1997. Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94:1862-1865.
5. Cabana, M., G. Fernandez, M. Parera, B. Clotet, and M. A. Martinez. 2002. Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions. Virology 300:71-78.
6. Ceccherini-Silberstein, F., F. Erba, F. Gago, A. Bertoli, F. Forbici, M. C. Bellocchi, C. Gori, R. D'Arrigo, L. Marcon, C. Balotta, A. Antinori, A. D. Monforte, and C. F. Perno. 2004. Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure. AIDS 18:F11-F19.
7. Charpentier, C., T. Nora, O. Tenaillon, F. Clavel, and A. J. Hance. 2006. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J. Virol. 80:2472-2482.
8. Chen, J., J. B. Anderson, C. DeWeese-Scott, N. D. Fedorova, L. Y. Geer, S. He, D. I. Hurwitz, J. D. Jackson, A. R. Jacobs, C. J. Lanczycki, C. A. Liebert, C. Liu, T. Madej, A. Marchler-Bauer, G. H. Marchler, R. Mazumder, A. N. Nikolskaya, B. S. Rao, A. R. Panchenko, B. A. Shoemaker, V. Simonyan, J. S. Song, P. A. Thiessen, S. Vasudevan, Y. Wang, R. A. Yamashita, J. J. Yin, and S. H. Bryant. 2003. MMDB: Entrez's 3D-structure database. Nucleic Acids Res. 31:474-477.
9. Chun, T. W., L. Carruth, D. Finzi, X. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, Y. H. Kuo, R. Brookmeyer, M. A. Zeiger, P. Barditch-Crovo, and R. F. Siliciano. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
10. Condra, J. H., W. A. Schleif, O. M. Blahy, L. J. Gabryelski, D. J. Graham, J. C. Quintero, A. Rhodes, H. L. Robbins, E. Roth, M. Shivaprakash, et al. 1995. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374:569-571.
11. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
12. Crandall, K. A., C. R. Kelsey, H. Imamichi, H. C. Lane, and N. P. Salzman. 1999. Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol. Biol. Evol. 16:372-382.
13. DeLano, W. L. 2002. The PyMOL molecular graphics system. DeLano Scientific, San Carlos, CA.
14. Delwart, E. L., H. Pan, A. Neumann, and M. Markowitz. 1998. Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance. J. Virol. 72:2416-2421.
15. Domingo, E., V. Martin, C. Perales, A. Grande-Perez, J. Garcia-Arriaza, and A. Arias. 2006. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 299:51-82.
16. Domingo, E., D. Sabo, T. Taniguchi, and C. Weissmann. 1978. Nucleotide sequence heterogeneity of an RNA phage population. Cell 13:735-744.
17. Eigen, M., and C. K. Biebricher. 1988. Sequence space and quasispecies distribution, p. 211-245. In E. Domingo, P. Ahlquist, and J. J. Holland (ed.), RNA genetics. CRC Press, Boca Raton, FL.
18. Eigen, M., and P. Schuster. 1979. The hypercycle. A principle of natural self-organization. Springer, Berlin, Germany.
19. Fernandez, G., A. Llano, M. Esgleas, B. Clotet, J. A. Este, and M. A. Martinez. 2006. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses. J. Gen. Virol. 87:1285-1294.
20. Franco, S., C. Tural, B. Clotet, and M. A. Martinez. 3 October 2006, posting date. Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1. Virus Res. doi:10.1016/j.virusres.2006.09.001.
21. Gehringer, H., J. R. Bogner, F. D. Goebel, H. Nitschko, and K. von der Helm. 2000. Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infected patients prior to HAART and possible implications on HAART. J. Clin. Virol. 17:137-141.
22. Guo, H. H., J. Choe, and L. A. Loeb. 2004. Protein tolerance to random amino acid change. Proc. Natl. Acad. Sci. USA 101:9205-9210.
23. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
24. Hoffman, N. G., C. A. Schiffer, and R. Swanstrom. 2003. Covariation of amino acid positions in HIV-1 protease. Virology 314:536-548.
25. Ibanez, A., B. Clotet, and M. A. Martinez. 2000. Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispecies. J. Gen. Virol. 81:85-95.
26. Ibanez, A., T. Puig, J. Elias, B. Clotet, L. Ruiz, and M. A. Martinez. 1999. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:1045-1049.
27. Jung, A., R. Maier, J. P. Vartanian, G. Bocharov, V. Jung, U. Fischer, E. Meese, S. Wain-Hobson, and A. Meyerhans. 2002. Multiply infected spleen cells in HIV patients. Nature 418:144.
28. Kapoor, A., M. Jones, R. W. Shafer, S. Y. Rhee, P. Kazanjian, and E. L. Delwart. 2004. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay. J. Virol. 78:7112-7123.
29. Kitrinos, K. M., J. A. Nelson, W. Resch, and R. Swanstrom. 2005. Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations. J. Virol. 79:10627-10637.
30. Kozal, M. J., N. Shah, N. Shen, R. Yang, R. Fucini, T. C. Merigan, D. D. Richman, D. Morris, E. Hubbell, M. Chee, and T. R. Gingeras. 1996. Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays. Nat. Med. 2:753-759.
31. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
32. Lech, W. J., G. Wang, Y. L. Yang, Y. Chee, K. Dorman, D. McCrae, L. C. Lazzeroni, J. W. Erickson, J. S. Sinsheimer, and A. H. Kaplan. 1996. In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J. Virol. 70:2038-2043.
33. Loeb, D. D., R. Swanstrom, L. Everitt, M. Manchester, S. E. Stamper, and C. A. Hutchison III. 1989. Complete mutagenesis of the HIV-1 protease. Nature 340:397-400.
34. Macken, C. A., and A. S. Perelson. 1989. Protein evolution on rugged landscapes. Proc. Natl. Acad. Sci. USA 86:6191-6195.
35. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
36. Martinez, M. A., M. Cabana, M. Parera, A. Gutierrez, J. A. Este, and B. Clotet. 2000. A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease. Antimicrob. Agents Chemother. 44:1132-1139.
37. Martinez, M. A., and B. Clotet. 2003. Genetic screen for monitoring hepatitis C virus NS3 serine protease activity. Antimicrob. Agents Chemother. 47:1760-1765.
38. Martinez-Picado, J., and R. D'Aquila. 1998. HIV-1 drug resistance assays in clinical management. AIDS Clin. Care 10:81-85, 87-88.
39. Meyerhans, A., R. Cheynier, J. Albert, M. Seth, S. Kwok, J. Sninsky, L. Morfeldt-Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
40. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
41. Nijhuis, M., C. A. Boucher, P. Schipper, T. Leitner, R. Schuurman, and J. Albert. 1998. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc. Natl. Acad. Sci. USA 95:14441-14446.
42. Nijhuis, M., R. Schuurman, D. de Jong, J. Erickson, E. Gustchina, J. Albert, P. Schipper, S. Gulnik, and C. A. Boucher. 1999. Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS 13:2349-2359.
43. Ota, T., and M. Nei. 1994. Variance and covariances of the numbers of synonymous and nonsynonymous substitutions per site. Mol. Biol. Evol. 11:613-619.
44. Page, R. D. 1996. Tree View: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358.
45. Parera, M., B. Clotet, and M. A. Martinez. 2004. Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease. J. Virol. 78:14057-14061.
46. Parera, M., G. Fernandez, B. Clotet, and M. A. Martinez. 7 November 2006, posting date. HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions. Mol. Biol. Evol. doi:10.1093/molbev/ msl168.
47. Parera, M., A. Ibanez, B. Clotet, and M. A. Martinez. 2004. Lack of evidence for protease evolution in HIV-1-infected patients after 2 years of successful highly active antiretroviral therapy. J. Infect. Dis. 189:1444-1451.
48. Resch, W., N. Parkin, T. Watkins, J. Harris, and R. Swanstrom. 2005. Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir. J. Virol. 79:10638-10649.
49. Rose, J. R., L. M. Babe, and C. S. Craik. 1995. Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J. Virol. 69:2751-2758.
50. Rouzine, I. M., and J. M. Coffin. 1999. Linkage disequilibrium test implies a large effective population number for HIV in vivo. Proc. Natl. Acad. Sci. USA 96:10758-10763.
51. Rouzine, I. M., and J. M. Coffin. 1999. Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus. J. Virol. 73:8167-8178.
52. Ruiz-Jarabo, C. M., A. Arias, E. Baranowski, C. Escarmis, and E. Domingo. 2000. Memory in viral quasispecies. J. Virol. 74:3543-3547.
53. Ruiz-Jarabo, C. M., A. Arias, C. Molina-Paris, C. Briones, E. Baranowski, C. Escarmis, and E. Domingo. 2002. Duration and fitness dependence of quasispecies memory. J. Mol. Biol. 315:285-296.
54. Shankarappa, R., J. B. Margolick, S. J. Gange, A. G. Rodrigo, D. Upchurch, H. Farzadegan, P. Gupta, C. R. Rinaldo, G. H. Learn, X. He, X. L. Huang, and J. I. Mullins. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
55. Sices, H. J., and T. M. Kristie. 1998. A genetic screen for the isolation and characterization of site-specific proteases. Proc. Natl. Acad. Sci. USA 95:2828-2833.
56. Smith, J. M. 1970. Natural selection and the concept of a protein space. Nature 225:563-564.
57. Swanstrom, R., and J. Erona. 2000. Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance. Pharmacol. Ther. 86:145-170.
58. Swofford, D. L. 2003. PAUP*: phylogenetic analysis using parsimony (*and other methods), version 4. Sinauer Associates, Sunderland, MA.
59. Vignuzzi, M., J. K. Stone, J. J. Arnold, C. E. Cameron, and R. Andino. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348.
60. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
61. Weinreich, D. M., N. F. Delaney, M. A. Depristo, and D. L. Hartl. 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-114.
62. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537-542.
63. Wu, T. D., C. A. Schiffer, M. J. Gonzales, J. Taylor, R. Kantor, S. Chou, D. Israelski, A. R. Zolopa, W. J. Fessel, and R. W. Shafer. 2003. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J. Virol. 77:4836-4847.
64. Yang, Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13:555-556.